Pomerantz LLP and Bronstein, Gewirtz & Grossman filed a securities class action Thursday in New York Southern District Court against Oscar Health and its top executives in connection with the company’s March 2021 IPO, which brought the company $1.3 billion in net proceeds, according to court documents.
The lawsuit accuses the defendants of misleading investors regarding the company’s growing COVID-19 testing and treatment costs. Counsel have not yet appeared for the defendants.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
